September 2010 Br J Cardiol 2010;17:211-14
Highlights of this year’s European Society of Cardiology Congress, held in Stockholm, Sweden, from August 28th to September 1st included a new drug which benefits heart failure by slowing heart rate, and more exciting results from oral compounds that could replace warfarin in various indications. Highlights of this year’s European Society of Cardiology Congress, held in Stockholm, Sweden, from August 28th to September 1st included a new drug which benefits heart failure by slowing heart rate, and more exciting results from oral compounds that could replace warfarin in various indications. SHIFT: ivabradine shows benefit in heart failure
November 2009 Br J Cardiol 2009;16:281-6
Aateka Patel, Stuart A Jones, Albert Ferro, Nilesh Patel
(more…)
May 2004 Br J Cardiol 2004;11:195-04
Kim M Fox
No content available
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits